ask="31.80"
ask_size="1000"
average_daily_volume="247544"
bid="26.00"
bid_size="100"
book_value="3.79"
change="-0.47"
change_from_200_day_moving_average="5.88"
change_from_50_day_moving_average="0.53"
change_from_52_week_high="-2.88"
change_From_52_week_low="14.80"
change_in_percent="-1.60%"
close="28.92"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.07"
ebitda="-37.24M"
eps_estimate_current_year="-2.36"
eps_estimate_next_quarter="-0.54"
eps_estimate_next_year="-3.03"
ex_dividend_date="N/A"
float_shares="13741000"
high="29.90"
high_52_weeks="31.80"
last_trade_date="1/5/2017"
last_trade_price="28.92"
last_trade_size="3309"
last_trade_time="4:00pm"
low="28.23"
low_52_weeks="14.12"
market_capitalization="619.81M"
moving_average_200_day="23.04"
moving_average_50_day="28.39"
name="Aclaris Therapeutics
Inc."
notes="N/A"
one_year_target_price="38.17"
open="29.30"
pe_ratio="N/A"
peg_ratio="-0.19"
percent_change_from_200_day_moving_average="+25.54%"
percent_change_from_50_day_moving_average="+1.88%"
percent_change_from_52_week_high="-9.06%"
percent_change_from_52_week_low="+104.82%"
previous_close="29.39"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.76"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="21432000"
short_ratio="2.48"
stock_exchange="NMS"
symbol="ACRS"
volume="126279"
weeks_range_52="14.12 - 31.80"
